国际肿瘤学杂志 ›› 2017, Vol. 44 ›› Issue (8): 569-572.doi: 10.3760/cma.j.issn.1673-422X.2017.08.003

• 论著 • 上一篇    下一篇

NSCLC微波消融前后血清VEGF、Arg-1、iNOS水平变化及其相关性

聂雪蓉, 董亮亮, 张良明   

  1. 264000 烟台,青岛大学附属烟台毓璜顶医院肿瘤内一科
  • 出版日期:2017-08-08 发布日期:2017-07-21
  • 通讯作者: 张良明,Email: zhanglmdr@163.com E-mail: zhanglmdr@163.com
  • 基金资助:

    烟台市科技计划(2016WS004)

Changes of serum levels of VEGF, Arg-1 and iNOS in NSCLC patients before and after microwave ablation and their correlations

Nie Xuerong, Dong Liangliang, Zhang Liangming   

  1. First Department of Medical Oncology, Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai 264000, China
  • Online:2017-08-08 Published:2017-07-21
  • Contact: Zhang Liangming, Email: zhanglmdr@163.com E-mail: zhanglmdr@163.com
  • Supported by:

    Science and Technology Planning Project of Yantai (2016WS004)

摘要: 目的  探讨微波消融治疗非小细胞肺癌(NSCLC)的疗效,分析微波消融前后NSCLC患者血清血管内皮生长因子(VEGF)、精氨酸酶-1(Arg-1)、诱导型一氧化氮合酶(iNOS)浓度的变化及三者之间的关系。方法  选取30例健康体检者作为对照组,30例晚期NSCLC患者为试验组,用酶联免疫吸附试验(ELISA)法检测健康体检者、晚期NSCLC患者微波消融术前及术后第1天、第3天、1个月血清VEGF、Arg-1、iNOS浓度。结果  微波消融治疗晚期NSCLC的有效率为33.3%(10/30),疾病控制率为70.0%(21/30)。微波消融术前NSCLC患者血清VEGF、Arg1、iNOS浓度分别为(816.56±13.26)pg/ml、(5.17±0.20)ng/ml、(544.18±13.93)pg/ml,明显高于对照组的(93.43±9.93)pg/ml、(1.08±0.05)ng/ml、(8.08±0.33)pg/ml,差异均有统计学意义(t=239.093,P<0.001;t=110.359,P<0.001;t=210.792,P<0.001)。晚期NSCLC患者微波消融术后第1天、第3天、1个月血清VEGF浓度分别为(708.41±10.49)pg/ml、(592.63±7.25)pg/ml、(521.91±8.32)pg/ml,均较治疗前明显降低(均P<0.05);Arg-1浓度分别为(5.95±0.10)ng/ml、(7.02±0.13)ng/ml、(7.67±0.92)ng/ml,均较治疗前明显升高(均P<0.05);iNOS浓度分别为(453.01±9.48)pg/ml、(393.21±9.42)pg/ml、(352.60±8.31)pg/ml,均较治疗前明显降低(均P<0.05)。NSCLC患者治疗前血清iNOS与VEGF表达呈正相关(r=0.379,P=0.039),Arg1与VEGF表达呈负相关(r=-0.556,P=0.001),iNOS与Arg1表达无关(r=-0.238,P=0.205)。结论  微波消融是一种有效的NSCLC局部治疗手段,除可直接杀灭癌细胞外,亦可影响VEGF、Arg-1、iNOS表达水平,VEGF与iNOS和Arg-1有一定相关性,而iNOS与Arg-1无关。微波消融可在一定程度上改变肿瘤微环境,刺激机体产生抗肿瘤免疫。

关键词: 肺肿瘤, 放射疗法, 血管内皮生长因子类, 精氨酸酶-1, 诱导型一氧化氮合酶

Abstract: Objective  To investigate the curative effect of microwave ablation for non-small cell lung cancer (NSCLC) patients, and to analyze the serum concentration changes of vascular endothelial growth factor (VEGF), arginase-1 (Arg-1), inducible nitric oxide synthase (iNOS) before and after microwave ablation and their correlations. Methods  A total of 30 cases of healthy people (control group) and 30 cases of advanced NSCLC (test group) were selected. The serum concentrations of VEGF, Arg-1 and iNOS in control group and test group (before microwave ablation, the first postoperative day, the third postoperative day and the first postoperative month) were measured by enzymelinked immunosorbent assay (ELISA). Results  The effective rate of microwave ablation for advanced NSCLC was 33.3% (10/30), and the disease control rate was 70.0% (21/30). The concentrations of VEGF, Arg-1 and iNOS in test group before microwave ablation were (816.56±13.26)pg/ml, (5.17±0.20)ng/ml and (544.18±13.93)pg/ml, which were higher than those in control group (93.43±9.93)pg/ml, (1.08±0.05)ng/ml and (8.08±0.33)pg/ml, and the differences were statistically significant (t=239.093, P<0.001; t=110.359, P<0.001;t=210.792, P<0.001). The concentrations of VEGF were (708.41±10.49)pg/ml, (592.63±7.25)pg/ml and (521.91±8.32) pg/ml on the first day, third day and 1 month after microwave ablation in patients with advanced NSCLC, which were significantly lower than those before treatment (all P<0.05). The homologous concentrations of Arg-1 were (5.95±0.10)ng/ml, (7.02±0.13)ng/ml and (7.67±0.92)ng/ml, which were significantly higher than those before treatment (all P<0.05). The homologous concentrations of iNOS were (453.01±9.48)pg/ml, (393.21±9.42)pg/ml and (352.60±8.31)pg/ml, which were significantly lower than those before treatment (all P<0.05). The expression of iNOS was positively related with VEGF in NSCLC patients before treatment (r=0.379,P=0.039), and the expression of Arg1 was negatively related with VEGF (r=-0.556, P=0.001). However, the expression of iNOS was not associated with Arg1 (r=-0.238, P=0.205). Conclusion  Microwave ablation is effective for local therapy of NSCLC, which can directly kill cancer cells, and affect the levels of VEGF, Arg-1 and iNOS. VEGF has certain correlation with iNOS and Arg-1, but there was no correlation between iNOS and Arg-1. Microwave ablation can change the tumor microenvironment in a certain extent, and stimulate the body to produce anti-tumor immunity.

Key words: Lung neoplasms, Radiation therapy, Vascular endothelial growth factors, Arginase-1, Inducible nitric oxide synthase